89 evolution "https:" "https:" "https:" "https:" "https:" "https:" "U.S" "University of St" scholarships at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
data from the European XFEL facility at DESY. Project website: https://www.mpinat.mpg.de/628848/SM-Ultrafast-XRay-Diffraction Your profile Eligible candidates have strong skills in computational physics
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
Smet ( https://desmetlab.sites.vib.be ) and F. Van Breusegem ( https://vanbreusegemlab.sites.vib.be ) have expertise in abiotic stress signaling and in advanced molecular profiling, including mass
-
English as the primary language. Career development support and mentoring throughout the program. Interdisciplinary coursework and research opportunities across different areas of science, engineering and
-
catalyst for many past successes: https://europepmc.org/article/MED/35021063 , https://europepmc.org/article/MED/31819264 , https://europepmc.org/article/MED/31561945 , https://europepmc.org/article/MED
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
, public authorities in their decisions and businesses in their strategies. Do you want to know more about LIST? Check our website: https://www.list.lu/ How will you contribute? You will develop a multi
-
You apply through our recruitment system on 30 March 2026, at the latest (https://umu.varbi.com/en/what:job/jobID:905098/ ). The application, written in English, should include: A short (max 2 pages
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient